Back to Journals » Drug Design, Development and Therapy » Volume 17

Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy

Total article views   HTML views PDF downloads Totals
3,470 Dovepress* 3,276+ 80 3,356
PubMed Central* 194 90 284
Totals 3,470 170 3,640
*Since 16 February 2023

View citations on PubMed Central and Google Scholar